How COVID-19 impact on healthcare industry and how long it will suffer?

Answer 1

The global healthcare sector is very rapidly adopting the technologically advanced solutions to fight against the pandemic. Key players will be more concerned with the re-visiting of biotech companies’ pipeline strategies along with significant investment in disease prevention infrastructure after the COVID-19 pandemic crisis. The Coronavirus outbreak shall also lead to a boost in the digital transformation of health care delivery models, across the globe. The health care industry shall turn towards digital technologies for the prevention and monitoring of diseases, including the use of AI-based tools. Most of the global players are agree that the COVID-19 shall lead to profound changes in the dynamics of the global health care sector. In the long run, the outbreak of corona virus can catalyze the transformation of the global health care sector. However, the global healthcare industry will take a considerable time for Its recovery. Multiple firms around the globe, are at threat of missing their first-quarter targets.

Answer 2

Research institutions, biotech, and pharmaceutical companies are occupied in collaborative work to defeat the COVID-19 pandemic. In recent days, the healthcare sector is under dramatic pressure due to simultaneous involvement in several processes. The number of COVID-19 infections caused a thousand deaths and it is surging substantially. Currently, in the U.S., numerous market players are operating with their core competencies along with working on the development of a vaccine for COVID- 19. For instance, in March 2020, to assist COVID-19 patients Medtronic has launched a new ventilator platform. Furthermore, the governments and healthcare industries and are emphasizing highly on establishing infrastructure to defeat against COVID-19 pandemic crisis. The outbreak of COVID-19 has badly affected Asian countries as they are already facing the problem of shortage of healthcare infrastructure. To prevent the spread of COVID-19 pandemic, restrictive measures have been taken particularly in India, Malaysia, South Korea, and Singapore. Europe has been extremely hit by the crisis of COVID-19 affecting numerous countries such as Italy, Spain, Germany, and the UK. These countries are consistently experiencing extensive growth in the number of cases of coronavirus. Thus, In March 2020, the European Medicines Agency has created an executive committee to minimize the impact of COVID-19 on the pharmaceutical supply chain. Also, economies such as Brazil, Argentina, South-Africa, and Chile have responded to the situation by ordering quarantines and closing the border.

Answer 3

Research institutions, biotech, and pharmaceutical companies are occupied in collaborative work to defeat the COVID-19 pandemic. In recent days, the healthcare sector is under dramatic pressure due to simultaneous involvement in several processes. The number of COVID-19 infections caused a thousand deaths and it is surging substantially. Currently, in the U.S., numerous market players are operating with their core competencies along with working on the development of a vaccine for COVID- 19. For instance, in March 2020, to assist COVID-19 patients Medtronic has launched a new ventilator platform. Furthermore, the governments and healthcare industries and are emphasizing highly on establishing infrastructure to defeat against COVID-19 pandemic crisis. The outbreak of COVID-19 has badly affected Asian countries as they are already facing the problem of shortage of healthcare infrastructure. To prevent the spread of COVID-19 pandemic, restrictive measures have been taken particularly in India, Malaysia, South Korea, and Singapore. Europe has been extremely hit by the crisis of COVID-19 affecting numerous countries such as Italy, Spain, Germany, and the UK. These countries are consistently experiencing extensive growth in the number of cases of coronavirus. Thus, In March 2020, the European Medicines Agency has created an executive committee to minimize the impact of COVID-19 on the pharmaceutical supply chain. Also, economies such as Brazil, Argentina, South-Africa, and Chile have responded to the situation by ordering quarantines and closing the border.